Fulcrum Equity Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,606
Closed -$201K 197
2021
Q3
$201K Buy
+1,606
New +$208K 0.08% 176
2019
Q2
Sell
-2,700
Closed -$246K 108
2019
Q1
$246K Hold
2,700
0.08% 90
2018
Q4
$246K Buy
+2,700
New +$252K 0.09% 66

Other funds holding MDT

Fulcrum Equity Management's MDT Position: Q4 2021 in Review

Fulcrum Equity Management sold out of Medtronic (MDT) in Q4 2021, closing a stake of 1,606 shares — an estimated $201K sold.

Fulcrum Equity Management first reported a position in MDT in Q4 2018 and held it in 3 quarters. The position peaked at $246K in Q1 2019. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Fulcrum Equity Management reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Fulcrum Equity Management sold 1,606 Medtronic shares in Q4 2021, an estimated $201K.
  • Fulcrum Equity Management first reported a position in Medtronic in Q4 2018 and held it in 3 quarters.
  • Fulcrum Equity Management's Medtronic position peaked at $246K in Q1 2019.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Fulcrum Equity Management's 13F filing for Q4 2021, filed 25 Jan 2022.